The IOSI guidelines were prepared through a joint effort between the services of medical oncology, radiation therapy, nuclear medicine, hematology, palliative care and research that are gathered since 1999 under the "IOSI" roof.
The guidelines for each of the major cancer diseases, therapeutic attitudes to date of our institution, listed in priority order preceded by a list of fundamental investigations for staging. Generally you will find for every disease an overview of the management strategy and the respective explanatory notes.
The guidelines also contain the drug therapy schemes divided into three groups: the anticancer agents in monotherapy, the polychemotherapy and therapy to be administered in conjunction with radiotherapy.